$7.6M Partnership Advances Gene Therapy for Rare Muscle Disease

A nonprofit and patient foundation just committed $7.

65 million to develop a gene therapy for a rare muscular dystrophy with no current treatments.

The partnership will take the therapy from initial design all the way to human clinical trials.